Citius Pharmaceuticals CTXRW 深 沪
已收盘 08-08 16:00:00 美东时间
0.1441
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.1441
- 总市值 1941.04万
- 52周最高 1.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.012
- 委 比 0.00%
- 总股本 1.35亿
- 历史最高 2.89
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.012
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Citius Oncology在ASCO公布LYMPHIR联合帕博利珠单抗治疗妇科肿瘤I期数据
Citius Oncology， Inc．近日在2026年美国临床肿瘤学会年会上，以壁报形式公布了LYMPHIR联合帕博利珠单抗治疗复发或难治性妇科恶性肿瘤...
06-01 22:59
Citius Oncology Presents Phase 1 Clinical Data Of LYMPHIR In Combination With Pembrolizumab In Patients With Recurrent Or Refractory Gynecologic Malignancies At American Society Of Clinical Oncology Annual Meeting
Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (NASDAQ:CTXR), today highlighted
06-01 19:21
HC Wainwright & Co. Assumes Citius Pharmaceuticals at Buy, Announces Price Target of $4
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Citius Pharmaceuticals (NASDAQ:CTXR) with a Buy rating and announces Price Target of $4.
05-18 23:06
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
Citius Pharmaceuticals ( ($CTXR) ) just unveiled an update. On May 4, 2026, Cit...
05-09 06:05
Citius Expands LYMPHIR Access with First European Shipment
Citius Pharmaceuticals ( ($CTXR) ) has shared an update. On April 29, 2026, Cit...
04-30 06:33
Citius Oncology Ships First International Order of LYMPHIR™ to Europe
Order fulfilment expands international patient access to LYMPHIR following initial U.S. launch Distribution by regional partners through Named Patient Programs in specific international mark...
04-29 20:00
What's Behind The Drop In Citius Pharmaceuticals?
Citius Pharmaceuticals (NASDAQ:CTXR) shares tumbled on Friday after it announced a registered direct offering, raising dilution concerns.
04-24 22:47
Citius Pharmaceuticals to raise $5M in equity offering
Citius Pharmaceuticals (CTXR) said it entered a definitive agreement to sell about 5.08M shares of common stock, or pre-funded warrants, at $0.985 per share in a registered direct offering priced at t...
04-24 20:20
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
Citius Pharmaceuticals ( ($CTXR) ) has issued an announcement. On April 6, 2026...
04-07 05:15
